The UnitedHealth Mirage: A Stock’s Illusory Triumph

Shares of UnitedHealth Group (UNH) have ascended with the giddy enthusiasm of a moth to a flame, rising 8.8% by 2:23 p.m. ET. This fleeting triumph, however, is less a signal of salvation and more a waltz with the absurd. The S&P 500 and Nasdaq Composite, those pallid specters of market sentiment, have offered a tepid nod of approval-though one suspects their interest is purely transactional.

The company’s recent regulatory filing, a document one might mistake for a suicide note, claims it will achieve its Medicare Advantage enrollment targets. A feat, one supposes, if one conflates survival with victory. The data-78% of members enrolled in four-star plans-bears the weight of mediocrity. It is the sort of statistic that would make a statistician weep, yet here it is, paraded about like a peacock with a single pearl.

Loading widget...

UnitedHealth Hits Medicare Targets, Barely

The company’s triumph over triviality is underscored by its revenue model: a grotesque alchemy where higher star ratings translate to fatter margins. One might admire the ingenuity, were it not so plainly a house of cards. The 78% figure is not a beacon of progress but a flickering candle in a gale of mismanagement. It is the sort of achievement that would make a lesser man weep into his brandy.

The Unavoidable Collapse

UnitedHealth’s woes, of course, are legion. The CEO’s departure-ostensibly for “personal reasons”-smells of a staged exit. The DOJ’s investigations, those tedious bureaucratic rituals, will no doubt conclude with a shrug and a fat settlement. And let us not forget the nursing home bonuses: a system so grotesque it would make Dickens blush. Here, then, is the rub: the company’s revenue is tethered not to care, but to the artful avoidance of care.

Investors, in their infinite wisdom, have chosen to believe in a phoenix rising from the ashes of its own incompetence. But let us not delude ourselves: this is no phoenix. It is a paper tiger with a mortgage. For the contrarian, the lesson is clear-profit from the folly, but do so with a shudder and a sigh. UnitedHealth is not a stock to own. It is a cautionary tale, and a very good one at that. 🪦

Read More

2025-09-09 22:32